| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.87B | 64.26B | 41.92B | 54.15B | 39.57B | 29.56B |
| Gross Profit | 12.13B | 13.87B | 10.39B | 8.25B | 7.11B | 5.42B |
| EBITDA | 8.81B | 10.46B | 7.46B | 6.04B | 4.54B | 3.50B |
| Net Income | 5.14B | 6.05B | 4.39B | 3.45B | 2.44B | 10.36B |
Balance Sheet | ||||||
| Total Assets | 108.51B | 112.26B | 105.85B | 75.71B | 48.36B | 31.36B |
| Cash, Cash Equivalents and Short-Term Investments | 60.01B | 83.46B | 60.71B | 63.64B | 35.58B | 20.24B |
| Total Debt | 76.90B | 72.37B | 72.40B | 48.90B | 23.21B | 15.12B |
| Total Liabilities | 82.89B | 83.51B | 80.68B | 54.59B | 30.58B | 18.20B |
| Stockholders Equity | 25.62B | 28.75B | 25.17B | 21.11B | 17.78B | 13.16B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.00M | -26.51B | -26.66B | -4.52B | -814.00M |
| Operating Cash Flow | 0.00 | 13.00M | -26.51B | -26.65B | 3.71B | -772.00M |
| Investing Cash Flow | 0.00 | -254.00M | -123.00M | -189.00M | -8.43B | 26.08B |
| Financing Cash Flow | 0.00 | -1.60B | 22.93B | 25.62B | 9.94B | -22.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥107.82B | 9.51 | ― | 2.85% | 1.06% | -7.68% | |
65 Neutral | ¥1.19T | 8.84 | ― | 3.37% | 6.51% | 30.56% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥36.33B | 9.56 | ― | 3.90% | 53.30% | 35.91% | |
57 Neutral | ¥33.55B | 7.83 | ― | 4.66% | -8.90% | 9.92% | |
51 Neutral | ¥396.28B | 17.81 | ― | 3.62% | 16.26% | -52.33% |